4.5 Article

Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease

Related references

Note: Only part of the references are listed.
Editorial Material Gastroenterology & Hepatology

Use of Azathioprine and 6MP in Postoperative Crohn's: Changing Natural History or Just Along for the Ride?

Fernando S. Velayos et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis

Laurent Peyrin-Biroulet et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

Miguel Regueiro et al.

GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

Postoperative Therapy for Crohn's Disease

Eric Blum et al.

INFLAMMATORY BOWEL DISEASES (2009)

Review Gastroenterology & Hepatology

Safety and efficacy of strictureplasty for crohn's disease: A systematic review and meta-analysis

Takayuki Yamamoto et al.

DISEASES OF THE COLON & RECTUM (2007)

Letter Medicine, General & Internal

Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease

Dario Sorrentino et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Review Gastroenterology & Hepatology

Review article: the burden of hepatic encephalopathy

F. F. Poordad

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)

Article Gastroenterology & Hepatology

Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial

S. Takagi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Article Gastroenterology & Hepatology

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease

S Ardizzone et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?

A Alves et al.

INFLAMMATORY BOWEL DISEASES (2004)

Article Gastroenterology & Hepatology

Infliximab decreases resource use among patients with Crohn's disease

JH Rubenstein et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)

Article Gastroenterology & Hepatology

Crohn's disease in Japan - Diagnostic criteria and epidemiology

T Yao et al.

DISEASES OF THE COLON & RECTUM (2000)